Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Clinical and Immunological Implications of Frameshift Mutations in Lung CancerYoung Kwang Chae, Pedro Viveiros, Gilberto Lopes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
The pan-tumor landscape of gene amplifications and copy number amplification ratio for established and emerging clinical targetsJessica K Lee, Julia C F Quintanilha, Kuei-Ting Chen, et al.
JCO Precision Oncology|September 14, 2020
Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV- Forms Reveals Distinct Sets of Potentially Actionable Molecular TargetsErik A Williams, Adrienne J Werth, Radwa Sharaf, et al.
The Journal of Molecular Diagnostics : JMD|August 22, 2025
High-Specificity Detection of UV Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors Using FoundationOne Liquid CDxDouglas A Mata, Angela A Kou, Andreas M Heilmann, et al.
Translational Oncology|August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitorsJonathan W Riess, Shaila Rahman, Waleed Kian, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Cancer Cell|November 20, 2018
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain MutationsKanika Bajaj Pahuja, Thong T Nguyen, Bijay S Jaiswal, et al.
The Oncologist|October 13, 2019
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRAUmut Disel, Russell Madison, Kumar Abhishek, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.
Pageof 32